Bucillamine Phase 2 Trial in Patients With Cystinuria
Clinical trial NCT02942420 · UNKNOWN
Trial details
- NCT number
- NCT02942420
- Sponsor
- Revive Therapeutics, Ltd.
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-05-01
- Primary completion
- 2018-03-01
- Enrollment
- 30
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.